Emergency news
All →Our emergency work in focus
All →
Publications
All →Filovirus disease outbreaks pose significant public health threats, and treatment centres have become essential infrastructure for outbreak response. This...
The allocation, disbursement and reporting of external and domestic funds during health emergencies:...
This guidance provides recommendations for the allocation, disbursement, use, and reporting of domestic and external resources during disease outbreaks....
This executive summary presents the WHO guidelines for the clinical management of filovirus disease, encompassing infections caused by Bundibugyo, Ebola,...
This WHO guideline provides evidence-based recommendations for the clinical management of filovirus disease, including disease caused by Ebola, Sudan,...
Documents
All →
In May 2026 (epidemiological weeks 19 to 22), a total of 29 610 new cholera and acute watery diarrhoea (AWD) cases were reported from 16 countries, territories,...
WHO Rapid Risk Assessment -Yellow fever, Global v.1
This Rapid Risk Assessment (RRA) aims to assess the risk of yellow fever at the global level, considering the public health impact, the risk of geographical...
In April 2026 (epidemiological weeks 14 to 17), a total of 20 100 new cholera and acute watery diarrhoea (AWD) cases were reported from 15 countries, territories,...
WHO advises Member States to implement a risk-based approach to the identification, monitoring, and management of contacts of probable or confirmed Andes...
More about our work in emergencies
Tracking SARS-CoV-2 variants
Overview
All viruses, including SARS-CoV-2, the virus that causes COVID-19, change over time. Most changes have little to no impact on the virus’s properties. However, some changes may affect the virus’s properties, such as how easily it spreads, the associated disease severity, or the performance of vaccines, therapeutic medicines, diagnostic tools, or other public health and social measures.
In June 2020, the WHO Virus Evolution Working Group was established with a specific focus on SARS-CoV-2 variants, their phenotype and their impact on countermeasures. This later became the Technical Advisory Group on SARS-CoV-2 Virus Evolution. In late 2020, the emergence of variants that posed an increased risk to global public health prompted WHO to characterize some as variants of interest (VOIs) and variants of concern (VOCs) in order to prioritize global monitoring and research, and to inform and adjust the COVID-19 response. From May 2021 onwards, WHO began assigning simple, easy-to-say labels for key variants.
Considerable progress has been made in establishing and strengthening a global system to detect signals of potential VOIs or VOCs and rapidly assess the risk posed by SARS-CoV-2 variants to public health. More specifically, in 2024 WHO launched a WHO Coronavirus Network (CoViNet) to facilitate early and accurate detection of coronaviruses and variant tracking including coordinating risk evaluations. It remains critical that these systems are maintained, and data are shared, according to good principles and in a timely fashion, as SARS-CoV-2 continues to circulate at high levels around the world. While monitoring the circulation of SARS-CoV-2 globally, it also remains essential to monitor their spread in animal populations and chronically infected individuals, which are crucial aspects of the global strategy to reduce the occurrence of mutations that have negative public health implications. In March 2023, WHO updated its tracking system and working definitions for variants of concern, variants of interest and variants under monitoring. They can be found here. The previous working definitions can be found here.